Table 2 Multivariable analysis of disease-free survival in patients with stage III squamous NSCLC.
From: Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
Variable | Reference | P value | HR | 95% CI | |
---|---|---|---|---|---|
Lower | Upper | ||||
Smurf2 expression | Quartile 1 | 0.16 | |||
Quartile 2 | 0.16 | 2.54 | 0.70 | 9.29 | |
Quartile 3 | 0.23 | 2.08 | 0.63 | 6.87 | |
Quartile 4 | 0.02 | 3.77 | 1.21 | 11.80 |